It may be possible to reduce the severity of COVID-19 symptoms with an inexpensive amino acid that could open up new treatment options for patients. GABA is a natural molecule that is available ...

For many people with schizophrenia, current antipsychotic medications have been far from perfect in curtailing their cognitive symptoms, leaving remission and recovery out of reach. Prior work has led ...

Researchers have found that practicing yoga may elevate brain gamma-aminobutyric levels, the brain's primary inhibitory neurotransmitter. The findings suggest that the practice of yoga be explored as ...

Zolpidem is a non-benzodiazepine agonist at benzodiazepine binding site in GABA A receptors, which is increasingly prescribed. Recent studies suggest that prolonged zolpidem treatment induces ...

Ovid stock surged 18% following positive Phase 1 data for OV329, and investors are getting excited about a forthcoming Phase 2.

Preclinical studies in mice that model human COVID-19 suggest that an inexpensive, readily available amino acid might limit the effects of the disease and provide a new off-the-shelf therapeutic ...

Scientists claim GABA administration preserves islet β-cell mass, stimulates β-cell regeneration, and blocks autoimmune response. Treating type 1 diabetes (T1D) with gamma-aminobutiric acid (GABA) ...

Diabetes is a disease affecting two pancreatic hormones — insulin and glucagon. In healthy people, insulin helps cells take up glucose from the blood when glucose levels are high. In contrast, ...

For the first time, humans with newly diagnosed type 1 diabetes, or T1D, have received two treatments called GABA and GAD that have shown promise in animal studies and in isolated human pancreas ...